Differentiation of division I (cfiA-negative) and division II (cfiA-positive) Bacteroides fragilis strains by matrix-assisted laser desorption/ionization time of-flight mass spectrometry

Journal of Medical Microbiology

Volumn 60, Issue 11, 2011, Pages 1584-1590

  Nagy, Elisabeth ^a   Becker, Simone ^b   Sóki, József ^a   Urbán, Edit ^a   Kostrzewa, Markus ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Fahrenheitstrasse   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARBAPENEM DERIVATIVE; CFIA PROTEIN; IMIPENEM; METALLO BETA LACTAMASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTEROIDES FRAGILIS; CONTROLLED STUDY; GENE EXPRESSION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

BACTERIAL PROTEINS; BACTEROIDES FRAGILIS; BETA-LACTAMASES; PRINCIPAL COMPONENT ANALYSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 80054721892     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.031336-0     Document Type: Article

References (31)

1. Aldridge, K. E., Ashcraft, D., O'Brien, M. & Sanders, C. V. (2003). Bacteremia due to Bacteroides fragilis group: distribution of species, B-lactamase production, and antimicrobial susceptibility patterns. Antimicrob Agents Chemother 47, 148-153.
2. Bizzini, A. & Greub, G. (2010). Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. Clin Microbiol Infect 16, 1614-1619.
3. Cerdeño-Tárraga, A. M., Patrick, S., Crossman, L. C., Blakely, G., Abratt, V., Lennard, N., Poxton, I., Duerden, B., Harris, B. & other authors (2005). Extensive DNA inversions in the B. fragilis genome control variable gene expression. Science 307, 1463-1465.
4. Drancourt, M. (2010). Detection of microorganisms in blood specimens using matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a review. Clin Microbiol Infect 16, 1620-1625.
5. Edwards-Jones, V., Claydon, M. A., Evason, D. J., Walker, J., Fox, A. J. & Gordon, D. B. (2000). Rapid discrimination between methicillinsensitive and methicillin-resistant Staphylococcus aureus by intact cell mass spectrometry. J Med Microbiol 49, 295-300.
6. Gherna, R. & Woese, C. R. (1992). A partial phylogenetic analysis of the "flavobacter-bacteroides" phylum: basis for taxonomic restructuring. Syst Appl Microbiol 15, 513-521.
7. Gutacker, M., Valsangiacomo, C. & Piffaretti, J. C. (2000). Identification of two genetic groups in Bacteroides fragilis by multilocus enzyme electrophoresis: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes. Microbiology 146, 1241-1254.
8. Gutacker, M., Valsangiacomo, C., Bernasconi, M. V. & Piffaretti, J. C. (2002). recA and glnA sequences separate the Bacteroides fragilis population into two genetic divisions associated with the antibiotic resistance genotypes cepA and cfiA. J Med Microbiol 51, 123-130.
9. Johnson, J. L. (1978). Taxonomy of the Bacteroides. I. Deoxyribonucleic acid homologies among Bacteroides fragilis and other saccharolytic Bacteroides species. Int J Syst Bacteriol 28, 245-256.
10. Johnson, J. L. & Ault, D. A. (1978). Taxonomy of the Bacteroides. II. Correlation of phenotypic characteristics with deoxyribonucleic acid homology groupings for Bacteroides fragilis and other saccharolytic Bacteroides species. Int J Syst Bacteriol 28, 257-268.
11. Marinach, C., Alanio, A., Palous, M., Kwasek, S., Fekkar, A., Brossas, J. Y., Brun, S., Snounou, G., Hennequin, C. & other authors (2009). MALDITOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole. Proteomics 9, 4627-4631.
12. Murray, P. R. (2010). Matrix-assisted laser desorption ionization timeof-flight mass spectrometry: usefulness for taxonomy and epidemiology. Clin Microbiol Infect 16, 1626-1630.
13. Nagy, E. (2010). Anaerobic infections: update on treatment considerations. Drugs 70, 841-858.
14. Nagy, E., Maier, T., Urban, E., Terhes, G., Kostrzewa, M. on behalf of the ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria (2009). Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-offlight mass spectrometry. Clin Microbiol Infect 15, 796-802.
15. Nagy, E., Urbán, E., Nord, C. E. on behalf of the ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria (2011). Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect 17, 371-379.
16. Parker, A. C. & Smith, C. J. (1993). Genetic and biochemical analysis of a novel Ambler class A b-lactamase responsible for cefoxitin resistance in Bacteroides species. Antimicrob Agents Chemother 37, 1028-1036.
17. Podglajen, I., Breuil, J. & Collatz, E. (1994). Insertion of a novel DNA sequence, 1S 1186, upstream of the silent carbapenemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis. Mol Microbiol 12, 105-114.
18. Podglajen, I., Breuil, J., Casin, I. & Collatz, E. (1995). Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. J Bacteriol 177, 5270-5275.
19. Rasmussen, B. A., Gluzman, Y. & Tally, F. P. (1990). Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636. Antimicrob Agents Chemother 34, 1590-1592.
20. Ruimy, R., Podglajen, I., Breuil, J., Christen, R. & Collatz, E. (1996). A recent fixation of cfiA genes in a monophyletic cluster of Bacteroides fragilis is correlated with the presence of multiple insertion elements. J Bacteriol 178, 1914-1918.
21. Sakamoto, M. & Benno, Y. (2006). Reclassification of Bacteroides distasonis, Bacteroides goldsteinii and Bacteroides merdae as Parabacteroides distasonis gen. nov., comb. nov., Parabacteroides goldsteinii comb. nov. and Parabacteroides merdae comb. nov. Int J Syst Evol Microbiol 56, 1599-1605.
22. Shah, H. N. (1990). The genus Bacteroides and related taxa. In The Prokaryotes, 2nd edn, pp. 3593-3607. Edited by A. Balows, H. G. Truper, M. Dworkin, W. Harder & K. H. Schleifer. Berlin: Springer-Verlag.
23. Snydman, D. R., Jacobus, N. V., McDermott, L. A., Ruthazer, R., Golan, Y., Goldstein, E. J., Finegold, S. M., Harrell, L. J., Hecht, D. W. & other authors (2007). National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother 51, 1649-1655.
24. Sóki, J., Urbán, E., Szoke, I., Fodor, E. & Nagy, E. (2000). Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary. J Med Microbiol 49, 427-430.
25. Sóki, J., Fodor, E., Hecht, D. W., Edwards, R., Rotimi, V. O., Kerekes, I., Urbán, E. & Nagy, E. (2004). Molecular characterization of imipenemresistant, cfiA-positive Bacteroides fragilis isolates from the USA, Hungary and Kuwait. J Med Microbiol 53, 413-419.
26. Sóki, J., Edwards, R., Hedberg, M., Fang, H., Nagy, E., Nord, C. E., on behalf of the ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria (2006). Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey. Int J Antimicrob Agents 28, 497-502.
27. Song, Y. L., Liu, C. X., McTeague, M. & Finegold, S. M. (2004). "Bacteroides nordii" sp. nov. and "Bacteroides salyersae" sp. nov. isolated from clinical specimens of human intestinal origin. J Clin Microbiol 42, 5565-5570.
28. Song, Y., Liu, C., Lee, J., Bolanos, M., Vaisanen, M. L. & Finegold, S. M. (2005). "Bacteroides goldsteinii sp. nov." isolated from clinical specimens of human intestinal origin. J Clin Microbiol 43, 4522-4527.
29. Terhes, G., Brazier, J. S., Sóki, J., Urbán, E. & Nagy, E. (2007). Coincidence of bft and cfiA genes in a multi-resistant clinical isolate of Bacteroides fragilis. J Med Microbiol 56, 1416-1418.
30. Thompson, J. S. & Malamy, M. H. (1990). Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus b-lactamase II. J Bacteriol 172, 2584-2593.
31. Wybo, I., De Bel, A., Soetens, O., Echahidi, F., Vandoorslaer, K., Van Cauwenbergh, M. & Piérard, D. (2011). Differentiation of cfiAnegative and cfiA-positive Bacteroides fragilis isolates by matrixassisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 49, 1961-1964.